Navigating international market approvals requires scientific precision, uncompromising integrity, and seamless document architecture. Jigsaw Regulatory Solution delivers end-to-end dossier compilation, CMC quality modules, and lifecycle compliance across the US, EU, GCC, Africa, CIS, and emerging regions.
From prescription formulations to wellness supplements, we assemble the regulatory pieces so your products reach global patients without costly delays.
Empowering Indian and international manufacturers and exporters with country-specific adaptation of dossiers, distributor technical support, and query responses.
Complete regulatory submission and compliance for Rx and OTC products from new marketing applications through approval and post-marketing lifecycle management.
Expert guidance for food and natural derivatives boosting health. Navigating disparate regional frameworks across FSSAI, Dietary Supplements, and Food Supplements.
Nutraceuticals are formulations prepared from food and natural derivatives that provide therapeutic and medicinal help to boost overall wellness. While categorized under FSSAI regulations in India, regulatory designations differ significantly worldwide—often governed as Dietary Supplements in the Americas and Australia, or strictly as Food Supplements across the GCC and Europe.
At Jigsaw Regulatory Solution, we provide clear guidance, ingredient acceptability screening, label claim validations, and compile submission-ready technical dossiers to obtain seamless approvals across GCC, Africa, Australia, and LATAM countries.
Every regulatory module crafted with scientific depth, audit-tested rigor, and adherence to relevant regional authority guidelines.
Comprehensive authoring of administrative data and Module 2 Quality Overall Summary (QOS) plus Module 3 CMC sections tailored precisely to market requirements.
Rigorous, line-by-line review of existing technical dossiers to uncover scientific or administrative deficiencies before regulatory authorities flag them.
Preparation of technically sound, scientifically grounded responses to deficiency letters and Requests for Additional Information (RFI) from global regulators.
Strategic adaptation of master dossiers into market-ready CTD, eCTD, and ACTD formats compliant with individual authority submission portals and XML schemas.
Expert evaluation of product classification and identification of the fastest, most cost-effective routes to market approval across target jurisdictions.
Chemistry, Manufacturing, and Controls (CMC) strategy development to ensure formulation and scale-up data satisfy both current and future regulatory requirements.
Early identification of potential regulatory vulnerabilities, technical blockers, and formulation challenges paired with actionable mitigation roadmaps.
Realistic project scheduling mapping out analytical studies, dossier compilation, translation phases, and statutory authority review windows.
Planning, authoring briefing documents, and formulating question packages for pre-submission meetings and scientific advice procedures with health agencies.
Comprehensive assessment comparing your existing domestic technical data against mandatory regulatory prerequisites of new target regions.
Authoring and filing of post-approval lifecycle variations for manufacturing changes, analytical updates, site transfers, and container closure alterations.
Timely preparation and compilation of 5-year renewal packages, consolidating variation history, benefit-risk assessments, and continuous GMP proof.
Regulatory filings for line extensions introducing new dosage strengths, modified release profiles, additional therapeutic indications, or alternative routes of administration.
Filing required annual periodic reports with authorities, documenting ongoing stability data, annual batch trends, and safety updates.
Revision of Summary of Product Characteristics (SmPC), Patient Information Leaflets (PIL), carton text, and multi-lingual artwork compliance.
Comprehensive three-step Nitrosamine evaluation covering Step 1 (Risk Assessment), Step 2 (Confirmatory Testing), and Step 3 (Changes to Marketing Authorization) strictly adhering to US FDA, EMA, and ICH M7(R1) expectations.
Authoring of scientific Environmental Risk Assessment (ERA) reports in accordance with EMA guideline EMEA/CHMP/SWP/4447/00 and FDA environmental assessment exemptions.
Consulting and advisory on modern GxP software implementations, 21 CFR Part 11 electronic records compliance, audit trail reviews, and validated regulatory documentation management.
Jigsaw Regulatory Solution acts as your rapid-response regulatory taskforce. We analyze deficiency letters, formulate defensible scientific answers, and conduct zero-defect pre-submission audits for your CTD/ACTD files.
From major stringent authorities to fast-growth semi-regulated markets, we prepare region-compliant submissions respecting climatic zones and local guidelines.
Comprehensive IND, NDA and ANDA submissions. Expertise In electronic Common Technical Document (eCTD v3.2.2 & v4.0), FDA pre-IND briefing packages, Type II API DMF filings, GDUFA compliance, Including Labeling & SPC and responding to FDA Complete Response Letters (CRLs).
Jigsaw Regulatory Solution, founded in 2026, is committed to working with unwavering integrity with clients to provide regulatory key solutions related to administrative and CMC data for Pharmaceutical and Nutraceutical products.
In an industry where a single documentation discrepancy can delay market entry by months, we believe that "Every Piece Matters." Whether structuring an eCTD submission for Europe, filing nutritional supplements in GCC, or justifying Zone IVb stability protocols, our methodology leaves zero margin for ambiguity.
Specializing in pharma and nutraceutical regulatory affairs, CMC authoring, and global registrations across the US, Europe, GCC, and African authorities.
Inspired by world-class regulatory standards, our five core principles guarantee that every client receives rigorous, transparent, and defensible work.
Uncompromising ethical standards, scientific honesty, and transparent data architecture. We stand behind every dossier, ensuring complete compliance that withstands stringent health authority audits.
Meticulous attention to every regulatory nuance. From administrative certificates and stability schedules to eCTD formatting, we leave zero margin for error or document discrepancy.
Rigorous technical pre-audits across Modules 1 through 5. Every analytical validation, specification, and CMC justification is preemptively challenged to prevent regulatory queries and approval delays.
High-impact, cost-effective regulatory consulting that maximizes client return on investment. Direct founder-led execution eliminates bloated agency overheads, delivering premium solutions at fair value.
Agile, rapid-response execution engineered to accelerate market authorization. We eliminate procedural friction and optimize every filing milestone, respecting critical launch timelines with zero wasted effort.
Connect directly with Deesha Modi and the Jigsaw Regulatory consulting desk to discuss your dossier, CMC strategy, or upcoming global submission.
We partner with generic pharmaceutical companies, nutraceutical brands, and chemical synthesis labs across India and internationally.
Fill out the regulatory details below for a quick evaluation and proposal.
Got questions about dossier timelines, eCTD validation, or multi-regional filings? Here are quick answers from our consultants.
